Executive Editor, Consumer News Division
Ernie Mundell is the Executive Editor of the Consumer News Division. With a career that began in the 1990s at Reuters Health, he specializes in health and wellness topics, covering areas such as consumer health, mental health care, and public health. His work has been featured in numerous publications, including the Lincoln Journal Star and HealthDay News, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ernie Mundell predominantly covers healthcare and scientific topics, with a focus on data-driven reporting. He may be most responsive to pitches that offer access to new research findings or data related to health, medical advancements, mental health, pregnancy-related issues, vision problems, kidney health and Alzheimer's disease.
Given the prevalence of articles citing data in his coverage attributes, it is likely that Ernie would appreciate pitches providing access to reliable and significant research studies or statistical analysis within the healthcare and scientific fields.
As he focuses on national coverage in the United States, relevant sources should have expertise or insights specific to the U.S. healthcare system or ongoing developments in medical research within the country.
This information evolves through artificial intelligence and human feedback. Improve this profile .
We appreciate you here at HealthDay. Please sign up for unlimited health news!
We appreciate you here at HealthDay. Please sign up for unlimited health news!
Pancreatic cancer can be a silent killer, especially for people who inherit mutant genes that greatly raise their risk for the disease.
Higher levels of cholesterol and body fat are more likely in folks who stay up late, new research finds.
Rising temperatures could be increasing risks to children's brain development. A new study finds that exposure to higher temperatures during pregnancy could spur neurological changes in infancy and beyond.
A clinical trial finds that an algorithm routinely used to rule out pulmonary embolism works in patients with cancer, too — and could avoid up to 80,000 CT scans per year in the US.
The first randomized trial of its kind concludes that an algorithm widely used to rule out pulmonary embolism (PE) can safely be extended to patients with cancer.
Industry trials focus on single drugs, while publicly funded trials often look at broader cancer care. It’s a ‘complementary’ approach, but pharma enrolls over 90% of patients.
MONDAY, Sept. 14, 2026 (HealthDay News) — Anyone looking for certainty in a psychiatric diagnosis may be disappointed, according to new Danish research.“Our stu
By: Ernie Mundell
MONDAY, Sept. 14, 2026 (HealthDay News) — New research suggests that the blood pressure and heart rate guidelines doctors use to guide emergency treatment in ch
